Billionaire Profile
Vikram Punia
Global Rank
#2069

Image: Unsplash Contributor | Unsplash License | via Unsplash

Vikram Punia

CEO, Pharmaceuticals
RUSSIA
Real-Time Net Worth
$2.03B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
0% (24h)
Age
53
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
RUSSIA

Biography

Vikram Punia is a Russian billionaire and the sole owner of Pharmasyntez, a leading pharmaceutical company in Russia. His source of wealth stems from the healthcare industry, specifically from the production of a wide range of medications, including those for tuberculosis, HIV, and cancer. Punia's career began in Russia in 1992, when he arrived in Irkutsk as a student. He founded Pharmasyntez in 1997, which has since become a major player in the Russian pharmaceutical market. As of March 2026, Punia's estimated net worth is $2.0 billion.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Vikram Singh Punia was born in Jaipur, India, in 1973. He came from a family with a wealthy background. In 1992, at the age of 19, he arrived in Irkutsk, Russia, through a student exchange program, to study medicine.

Rise to Success

Punia started his business journey by reselling goods like tea, leather jackets, and pantyhose. He later transitioned into the pharmaceutical industry, founding Pharmasyntez in 1997 in Irkutsk. The company initially repackaged generic antitubercular medicine imported from India. Over time, Pharmasyntez expanded, establishing multiple factories across Russia and producing a wide array of medicines. In 2008, Punia moved the company's headquarters to Moscow. In 2009, he became a Russian citizen and, in 2010, became the sole owner of Pharmasyntez.

Key Business Strategies

Pharmasyntez focused on producing high-quality, affordable medicines for critical diseases, including tuberculosis, HIV, and cancer. The company also played a role in producing the Sputnik Light coronavirus vaccines during the COVID-19 pandemic. Vikram Punia emphasized import substitution, replacing imported drugs with Russian-made alternatives, and pursued vertical integration, encompassing R&D, manufacturing, and distribution.

Philanthropy

While specific philanthropy amounts are unavailable, Pharmasyntez focuses on providing affordable medicines for critical diseases.

Career Milestones

1997

Founded Pharmasyntez

Established pharmaceutical company in Irkutsk, Russia

2008

Moved Headquarters to Moscow

Relocated Pharmasyntez's headquarters to Moscow

2009

Became a Russian Citizen

Obtained Russian citizenship

2010

Sole Ownership of Pharmasyntez

Became the sole owner of Pharmasyntez

2024

Order of Friendship

Awarded the Order of Friendship by the President of the Russian Federation

Philanthropy & Social Impact

Healthcare

Affordable Medicines

N/A

Providing affordable medications for the treatment of diseases like tuberculosis, HIV, and cancer.

Business Philosophy & Leadership

Notable Quotes

""To make life better, we should cooperate...""

Leadership Principles

Focus on Innovation

Investing in new developments and innovations, rather than solely expanding the generics portfolio

Import Substitution

Replacing imported drugs with Russian-made alternatives

Vertical Integration

Controlling R&D, manufacturing, and distribution for efficiency and quality

Controversies & Challenges

N/A

Allegations of Unethical Practices

There are accusations of trading counterfeit goods against Pharmasyntez.